Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP825895.RABUMBjA2I3H2HX0h17Gcg5I2XTAZgdCW0iqq1L1G62Do130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825895.RABUMBjA2I3H2HX0h17Gcg5I2XTAZgdCW0iqq1L1G62Do130_provenance.
• NP236473.RADeSelti72B4aZVfz6xmeRoFwKE6PY-pmRfpRn57522w130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236473.RADeSelti72B4aZVfz6xmeRoFwKE6PY-pmRfpRn57522w130_provenance.
• NP505186.RAiw6Ddqdx6G-dJQAslB7a2wkp846nDwrFsc4xiTQ4qXg130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505186.RAiw6Ddqdx6G-dJQAslB7a2wkp846nDwrFsc4xiTQ4qXg130_provenance.
• NP443304.RAj1Zq9VxEWcHGCsbqO_nVVntAerqltKkTCDfM3CuQeow130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443304.RAj1Zq9VxEWcHGCsbqO_nVVntAerqltKkTCDfM3CuQeow130_provenance.
• NP488657.RAXzg6f_27O_-voK33K7GLSwRfNqzaH2gTHbqjFWlYviE130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488657.RAXzg6f_27O_-voK33K7GLSwRfNqzaH2gTHbqjFWlYviE130_provenance.
• NP714891.RAeuM2-NBWKAJCyrhE5zlTsUbLhF_EbQvwMPzIdieJS2U130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714891.RAeuM2-NBWKAJCyrhE5zlTsUbLhF_EbQvwMPzIdieJS2U130_provenance.
• assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP560261.RAb5XOw8dCQUJt8FKOmNYZHskWfQZ-Ch3Q2jPOPNSGTzU130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560261.RAb5XOw8dCQUJt8FKOmNYZHskWfQZ-Ch3Q2jPOPNSGTzU130_provenance.
• NP560262.RAdQqbLqVteLWAQ3Js599u7mfwCUbLYpO08DpPnMCrRec130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560262.RAdQqbLqVteLWAQ3Js599u7mfwCUbLYpO08DpPnMCrRec130_provenance.
• NP1009331.RAjS8Wvs3RZIS2EcOH2Thb6RAj-gt9hdjl01nNlqhl7mo130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009331.RAjS8Wvs3RZIS2EcOH2Thb6RAj-gt9hdjl01nNlqhl7mo130_provenance.
• NP560255.RAj994gW9mjde2AqwLJc4HfE7gU2N_8eGuG_zmOcyGDFI130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560255.RAj994gW9mjde2AqwLJc4HfE7gU2N_8eGuG_zmOcyGDFI130_provenance.
• NP560264.RAhC4vmUIvNO2PHLaea3-7UgqRPJxEIGuKcbEbqEMlKDk130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560264.RAhC4vmUIvNO2PHLaea3-7UgqRPJxEIGuKcbEbqEMlKDk130_provenance.
• NP714754.RAw8QxGcrooAr_lIAJkoHc-SuVPNDzrNEk6PLbG7d7t04130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714754.RAw8QxGcrooAr_lIAJkoHc-SuVPNDzrNEk6PLbG7d7t04130_provenance.
• NP715004.RAzNF3NAoypDBr7wnvBG_dcgaPG2TdRorwK7v2zZPglP8130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715004.RAzNF3NAoypDBr7wnvBG_dcgaPG2TdRorwK7v2zZPglP8130_provenance.
• NP721334.RA7-v8VEmEVtdw_iQVAjnlaxSo3TFbquin2Vu76bkOIJI130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721334.RA7-v8VEmEVtdw_iQVAjnlaxSo3TFbquin2Vu76bkOIJI130_provenance.
• NP560258.RA4kb-_ZrDezz2cWa9-LX6Qrnpg6_k8Qts4eLsE6Hocks130_assertion description "[Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560258.RA4kb-_ZrDezz2cWa9-LX6Qrnpg6_k8Qts4eLsE6Hocks130_provenance.